Utility of telemedicine in the treatment of patients with chronic HCV infection using DAAs in remote areas with limited resources

Liver Int. 2021 Aug;41(8):1979-1980. doi: 10.1111/liv.14982. Epub 2021 Jul 4.
No abstract available

Publication types

  • Letter
  • Comment

MeSH terms

  • Antiviral Agents / therapeutic use
  • Hepacivirus
  • Hepatitis C* / drug therapy
  • Humans
  • Telemedicine*

Substances

  • Antiviral Agents